We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

Two sleeves of oral medication.

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

A network of green vessels with parts highlighted in red.

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Tobacco, Drug Use in Pregnancy Can Double Risk of Stillbirth

NIH network study documents elevated risk associated with marijuana, other substances.

Novel Cancer Cell DNA Damage Repair Mechanism

Findings result from application of the cell microarray screening method developed at VTT.

AstraZeneca to Acquire Bristol-Myers Squibb Share of Global Diabetes Alliance Assets

Global agreement strengthens AstraZeneca’s commitment to diabetes.

Major Advance in Human Proteins

The paper, “Serial femtosecond crystallography of G-protein-coupled receptors,” reports the successful imaging, at room temperature, of the structure of GPCR with the use of an x-ray free-electron laser.

ThromboGenics Appoints Dr David Guyer to its Board of Directors

Dr Guyer is currently the Co-Founder and Chief Executive Officer of Ophthotech Corporation.

Cambridge Temperature Concepts Announces New CEO Claire Hooper

Internationally experienced executive joins innovative fertility venture to scale-up its operations.

Political Agreement on EU Clinical Trial Regulation Simplifies Rules But Misses its Initial Goal

UK patients miss out the chance to participate in developing the therapies of the future.

John van der Valk Appointed MD of UBM Live Amsterdam

Valk responsible for overseeing the company’s flagship brand CPhI.

Nuvo Research® and NovaMedica Sign Agreement to Market Pennsaid® in Russia

Sales of Pennsaid 1.5% in Russia to begin in 2015.

MorphoSys Strengthens Clinical Development Organization with Three Management Appointments

Appointment of Dr. Gabriele Elbl, Dr. Ludger Langer and Dr. Steffen Heeger.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter